ensembl_id string | gene string | gene_description string | uniprot list | chromosome string | position string | evidence string | hpa_evidence string | uniprot_evidence string | nextprot_evidence string | antibodies list | gene_synonyms list | protein_classes list | biological_processes list | molecular_functions list | disease_involvement list | subcellular_main_locations list | subcellular_additional_locations list | secretome_locations list | secretome_functions list | reliability_if string | reliability_ih string | reliability_mouse_brain string | interactions float64 | ccd_protein string | ccd_transcript string | blood_expression_cluster string | brain_expression_cluster string | cell_line_expression_cluster string | single_cell_expression_cluster string | tissue_expression_cluster string | rna_tissue_specificity string | rna_tissue_distribution string | rna_tissue_specificity_score float64 | rna_cell_line_specificity string | rna_cell_line_distribution string | rna_cell_line_specificity_score float64 | rna_cancer_specificity string | rna_cancer_distribution string | rna_cancer_specificity_score float64 | rna_single_cell_type_specificity string | rna_single_cell_type_distribution string | rna_single_cell_type_specificity_score float64 | rna_blood_cell_specificity string | rna_blood_cell_distribution string | rna_blood_cell_specificity_score float64 | prognostic_cancer_count int64 | validated_prognostic_cancer_count int64 | potential_prognostic_cancer_count int64 | favorable_prognostic_cancers list | unfavorable_prognostic_cancers list | prognostic_cancers list | source_row_index int64 | split_bucket int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ENSG00000110887 | DAO | D-amino acid oxidase | [
"P14920"
] | 12 | 108858932-108901043 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA038653",
"HPA038654"
] | [
"DAAO",
"DAMOX"
] | [
"Disease related genes",
"Enzymes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [] | [
"Oxidoreductase"
] | [
"Amyotrophic lateral sclerosis",
"Disease variant",
"Neurodegeneration",
"Schizophrenia"
] | [] | [] | [
"Intracellular and membrane"
] | [
"Enzyme"
] | null | Enhanced | null | 5 | null | null | null | Cluster 25: Non-specific - Transcription | Cluster 18: Liver cancer - Metabolism | Cluster 28: Astrocytes - Homeostasis & neuron support | Cluster 16: Liver & Kidney - Metabolism | Group enriched | Detected in some | 8 | Not detected | Not detected | null | Cancer enriched | Detected in some | 5 | Group enriched | Detected in some | 4 | Not detected in immune cells | Not detected | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 3,783 | 9 |
ENSG00000110888 | CAPRIN2 | Caprin family member 2 | [
"Q6IMN6"
] | 12 | 30709552-30823302 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA039746",
"HPA047794"
] | [
"C1QDC1",
"caprin-2",
"EEG1",
"FLJ11391",
"FLJ22569",
"RNG140"
] | [
"Predicted intracellular proteins"
] | [
"Differentiation",
"Growth regulation"
] | [
"Protein synthesis inhibitor",
"RNA-binding"
] | [] | [
"Cytosol"
] | [
"Nucleoplasm",
"Centrosome"
] | [] | [] | Supported | Enhanced | null | 4 | null | null | Cluster 24: Non-specific - Transcription | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 72: Neuronal - Signal transduction | Cluster 109: Neurons - Neuronal signaling | Cluster 46: Brain & retina - Neuronal signaling | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in many | null | 2 | 0 | 2 | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 3,784 | 8 |
ENSG00000110900 | TSPAN11 | Tetraspanin 11 | [
"A1L157"
] | 12 | 30926428-30996602 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA066789"
] | [] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [] | [] | [
"Vesicles"
] | [] | [] | [] | Approved | null | null | null | null | null | null | Cluster 15: Non-specific - Transcription | Cluster 12: Bone cancer - Neuronal signaling | Cluster 32: Endothelial cells - Angiogenesis & vascular immunity | Cluster 77: Intestine - Digestion | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Lung Adenocarcinoma"
] | [] | [
"Lung Adenocarcinoma"
] | 3,785 | 6 |
ENSG00000110906 | KCTD10 | Potassium channel tetramerization domain containing 10 | [
"Q9H3F6"
] | 12 | 109448655-109477359 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA014273"
] | [
"BTBD28",
"MSTP028"
] | [
"Predicted intracellular proteins"
] | [
"Ubl conjugation pathway"
] | [] | [] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Supported | Approved | null | 32 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 44: Non-specific - Mixed function | Cluster 61: BICR 18 - Protein kinases | Cluster 62: Smooth muscle cells - Muscle contraction | Cluster 12: Smooth muscle tissue - ECM organization | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 3,786 | 5 |
ENSG00000110911 | SLC11A2 | Solute carrier family 11 member 2 | [
"P49281"
] | 12 | 50979401-51028566 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA032139",
"HPA032140"
] | [
"DCT1",
"DMT-1",
"DMT1",
"FLJ37416",
"NRAMP2"
] | [
"Disease related genes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Ion transport",
"Iron transport",
"Symport",
"Transport"
] | [] | [
"Disease variant"
] | [
"Mitochondria"
] | [] | [] | [] | Supported | Uncertain | null | 5 | No | No | Cluster 33: Non-specific - ATP binding | Cluster 28: Oligodendrocytes - Mixed function | Cluster 57: Stomach & Colon cancer - Digestion | Cluster 40: Monocytes & Neutrophils - Inflammatory signaling | Cluster 69: Parathyroid gland - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in many | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 3,787 | 2 |
ENSG00000110917 | MLEC | Malectin | [
"Q14165"
] | 12 | 120687149-120701859 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"KIAA0152"
] | [
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Carbohydrate metabolism"
] | [] | [] | [] | [] | [] | [] | null | null | null | 29 | null | null | Cluster 29: Non-specific - Unknown function | Cluster 46: Brainstem - Mixed function | Cluster 57: Stomach & Colon cancer - Digestion | Cluster 54: Intestinal epithelial cells - Intestinal epi homeostasis & respiration | Cluster 76: Non-specific - Metabolism | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in many | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 3,788 | 1 |
ENSG00000110921 | MVK | Mevalonate kinase | [
"Q03426"
] | 12 | 109573255-109598125 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA016961",
"HPA044110"
] | [
"LRBP",
"MK"
] | [
"Disease related genes",
"Enzymes",
"Essential proteins",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Cholesterol biosynthesis",
"Cholesterol metabolism",
"Lipid biosynthesis",
"Lipid metabolism",
"Steroid biosynthesis",
"Steroid metabolism",
"Sterol biosynthesis",
"Sterol metabolism"
] | [
"Kinase",
"Transferase"
] | [
"Cataract",
"Disease variant"
] | [
"Vesicles",
"Cytosol"
] | [] | [] | [] | Supported | Approved | null | 11 | null | null | Cluster 13: Non-specific - Mitochondria | Cluster 49: Hindbrain - Mixed function | Cluster 66: Non-specific - Mitochondria | Cluster 49: Apical squamous epithelium - Epithelial barrier & keratinization | Cluster 31: Liver - Metabolism & Coagulation | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 3,789 | 7 |
ENSG00000110925 | CSRNP2 | Cysteine and serine rich nuclear protein 2 | [
"Q9H175"
] | 12 | 51061205-51083664 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA018503",
"HPA019914"
] | [
"C12ORF2",
"C12orf22",
"FAM130A1",
"PPP1R72",
"TAIP-12"
] | [
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Apoptosis",
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding"
] | [] | [
"Nuclear speckles"
] | [] | [] | [] | Approved | Approved | null | 7 | null | null | Cluster 3: Non-specific - Nuclear processes | Cluster 14: Neurons - Synaptic function | Cluster 38: Non-specific - Transcription | Cluster 65: Non-specific - Cell growth & division | Cluster 25: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in some | null | 0 | 0 | 0 | [] | [] | [] | 3,790 | 7 |
ENSG00000110931 | CAMKK2 | Calcium/calmodulin dependent protein kinase kinase 2 | [
"Q96RR4"
] | 12 | 121237675-121298308 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA017389",
"HPA063713"
] | [
"CAMKK",
"CAMKKB",
"KIAA0787",
"MGC15254"
] | [
"Enzymes",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [
"Calmodulin-binding",
"Kinase",
"Serine/threonine-protein kinase",
"Transferase"
] | [] | [
"Cytosol"
] | [] | [] | [] | Supported | Approved | Supported | 14 | null | null | Cluster 25: Non-specific - Unknown function | Cluster 15: Non-specific - Transcription | Cluster 38: Non-specific - Transcription | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 27: Cerebellum - Synaptic function | Tissue enriched | Detected in all | 9 | Low cancer specificity | Detected in all | null | Cancer enriched | Detected in all | 4 | Cell type enhanced | Detected in many | null | Group enriched | Detected in all | 4 | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 3,791 | 2 |
ENSG00000110934 | BIN2 | Bridging integrator 2 | [
"Q9UBW5"
] | 12 | 51281038-51324668 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA038666",
"HPA038667"
] | [
"BRAP-1"
] | [
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Plasma membrane"
] | [] | [] | [] | Enhanced | Enhanced | null | 4 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 20: Macrophages & Microglia - Immune response | Cluster 49: HMC-1 - Innate immune response | Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity | Cluster 29: Lymphoid tissue & Bone marrow - Innate immune response | Tissue enhanced | Detected in many | null | Group enriched | Detected in some | 5 | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 3,792 | 9 |
ENSG00000110944 | IL23A | Interleukin 23 subunit alpha | [
"Q9NPF7"
] | 12 | 56334174-56340410 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA001554"
] | [
"IL-23",
"IL-23A",
"IL23P19",
"P19",
"SGRF"
] | [
"FDA approved drug targets",
"Predicted secreted proteins"
] | [
"Antiviral defense",
"Immunity",
"Inflammatory response",
"Innate immunity",
"Tissue remodeling"
] | [
"Cytokine"
] | [
"FDA approved drug targets"
] | [
"Cytosol"
] | [] | [
"Secreted to blood"
] | [
"Interleukin"
] | Approved | Approved | null | 5 | null | null | Cluster 43: Non-specific - Transcription & Translation | Cluster 20: Macrophages & Microglia - Immune response | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 82: Dendritic cells - Antigen presentation | Cluster 11: Esophagus - Basic cellular processes | Tissue enriched | Detected in some | 5 | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in many | 7 | 2 | 0 | 2 | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma"
] | 3,793 | 4 |
ENSG00000110955 | ATP5F1B | ATP synthase F1 subunit beta | [
"P06576"
] | 12 | 56638175-56645984 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA001520",
"HPA001528",
"CAB017527"
] | [
"ATP5B",
"ATPSB"
] | [
"Enzymes",
"Essential proteins",
"Metabolic proteins",
"Plasma proteins",
"Predicted intracellular proteins",
"Transporters"
] | [
"ATP synthesis",
"Hydrogen ion transport",
"Ion transport",
"Transport"
] | [
"Translocase"
] | [
"Disease variant"
] | [
"Mitochondria"
] | [] | [] | [] | Enhanced | Enhanced | null | 116 | null | null | Cluster 26: Monocytes - Plasma membrane proteins | Cluster 23: Choroid plexus - Mixed function | Cluster 7: Liver cancer - Metabolism | Cluster 97: Non-specific - Cellular respiration | Cluster 52: Non-specific - Cellular respiration | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 4 | 0 | 4 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Chromophobe",
"Lung Adenocarcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma"
] | 3,794 | 1 |
ENSG00000110958 | PTGES3 | Prostaglandin E synthase 3 | [
"Q15185"
] | 12 | 56663341-56688408 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB034319",
"HPA038672",
"HPA038673"
] | [
"cPGES",
"p23",
"TEBP"
] | [
"Enzymes",
"Metabolic proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Fatty acid biosynthesis",
"Fatty acid metabolism",
"Lipid biosynthesis",
"Lipid metabolism",
"Prostaglandin biosynthesis",
"Prostaglandin metabolism"
] | [
"Chaperone",
"Isomerase"
] | [] | [
"Cytosol"
] | [
"Nucleoplasm"
] | [] | [] | Approved | Enhanced | null | 201 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 28: Oligodendrocytes - Mixed function | Cluster 38: Non-specific - Transcription | Cluster 75: Non-specific - Chaperones and protein folding | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 4 | 2 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 3,795 | 6 |
ENSG00000110975 | SYT10 | Synaptotagmin 10 | [
"Q6XYQ8"
] | 12 | 33374238-33439819 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [
"HPA055426"
] | [] | [
"Predicted membrane proteins"
] | [
"Exocytosis"
] | [] | [] | [
"Nucleoplasm",
"Vesicles"
] | [] | [] | [] | Approved | null | null | 1 | null | null | null | Cluster 24: Neurons - Mixed function | Cluster 10: Ciliated cells - Ion channel activity | Cluster 59: Pituitary endocrine cells - Neuroendocrine signaling | Cluster 48: Ciliated tissues - Cilium organization | Tissue enhanced | Detected in single | null | Not detected | Not detected | null | Cancer enriched | Detected in single | 4 | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 3,796 | 2 |
ENSG00000110987 | BCL7A | BAF chromatin remodeling complex subunit BCL7A | [
"Q4VC05"
] | 12 | 122019422-122062044 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA019762"
] | [
"BCL7",
"SMARCJ1"
] | [
"Cancer-related genes",
"Disease related genes",
"Predicted intracellular proteins"
] | [] | [] | [
"Cancer-related genes"
] | [
"Nucleoplasm",
"Vesicles"
] | [] | [] | [] | Approved | Approved | null | 24 | null | null | Cluster 23: B-cells - Immunoglobulins | Cluster 53: Neurons - Mixed function | Cluster 46: Lymphoma - Humoral immune response | Cluster 87: B-cells - Adaptive immunity: Humoral response | Cluster 27: Cerebellum - Synaptic function | Low tissue specificity | Detected in all | null | Cancer enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Group enriched | Detected in some | 6 | 3 | 0 | 3 | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | [
"Ovary Serous Cystadenocarcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | 3,797 | 1 |
ENSG00000111011 | RSRC2 | Arginine and serine rich coiled-coil 2 | [
"Q7L4I2"
] | 12 | 122503454-122527000 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA040070",
"HPA048183"
] | [
"FLJ11021"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nuclear speckles"
] | [
"Nucleoli fibrillar center",
"Cytosol"
] | [] | [] | Approved | Enhanced | null | 9 | No | No | Cluster 36: Eosinophils - Protein ubiquitination | Cluster 4: Non-specific - mRNA splicing & Cell cycle | Cluster 38: Non-specific - Transcription | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 15: Bone marrow - Innate immune response | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 3,798 | 7 |
ENSG00000111012 | CYP27B1 | Cytochrome P450 family 27 subfamily B member 1 | [
"O15528"
] | 12 | 57762334-57768986 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"CYP1",
"P450c1",
"PDDR",
"VDD1"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Lipid metabolism"
] | [
"Monooxygenase",
"Oxidoreductase"
] | [
"Disease variant"
] | [] | [] | [] | [] | null | null | null | null | null | null | null | null | Cluster 7: Liver cancer - Metabolism | Cluster 4: Breast lactating luminal cells - Lactation | Cluster 72: Kidney - Transmembrane transport | Tissue enhanced | Detected in some | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in some | null | Immune cell enriched | Detected in single | 6 | 2 | 0 | 2 | [] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Thyroid Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Thyroid Carcinoma"
] | 3,799 | 2 |
ENSG00000111046 | MYF6 | Myogenic factor 6 | [
"P23409"
] | 12 | 80707634-80709474 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA065102"
] | [
"bHLHc4",
"MRF4"
] | [
"Human disease related genes",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Differentiation",
"Myogenesis"
] | [
"Developmental protein",
"DNA-binding"
] | [] | [
"Nucleoplasm"
] | [
"Mitotic spindle",
"Cytosol"
] | [] | [] | Supported | null | null | 4 | Yes | null | null | Cluster 38: Sub-cortical - Mixed function | Cluster 5: Rhabdoid - Unknown function | Cluster 46: Skeletal myocytes - Muscle structure & formation | Cluster 19: Skeletal muscle - Striated muscle contraction | Group enriched | Detected in some | 37 | Cancer enhanced | Detected in single | null | Cancer enriched | Detected in some | 5 | Cell type enriched | Detected in some | 4 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Head and Neck Squamous Cell Carcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma"
] | 3,800 | 8 |
ENSG00000111049 | MYF5 | Myogenic factor 5 | [
"P13349"
] | 12 | 80716912-80719671 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA041691"
] | [
"bHLHc2"
] | [
"Disease related genes",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Differentiation",
"Myogenesis",
"Transcription",
"Transcription regulation"
] | [
"Activator",
"Developmental protein",
"DNA-binding"
] | [
"Disease variant"
] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | null | null | 22 | null | null | null | null | Cluster 33: Sarcoma - Muscle contraction | Cluster 46: Skeletal myocytes - Muscle structure & formation | Cluster 30: Skeletal muscle - Striated muscle contraction | Group enriched | Detected in some | 23 | Cancer enriched | Detected in single | 9 | Not detected | Not detected | null | Cell type enriched | Detected in single | 559 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 3,801 | 5 |
ENSG00000111052 | LIN7A | Lin-7 homolog A, crumbs cell polarity complex component | [
"O14910"
] | 12 | 80792520-80937934 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA071562"
] | [
"LIN-7A",
"MALS-1",
"TIP-33",
"VELI1"
] | [
"Predicted intracellular proteins"
] | [
"Exocytosis",
"Protein transport",
"Transport"
] | [] | [] | [] | [] | [] | [] | null | Approved | null | 32 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 2: Neurons - Nucleosome | Cluster 59: Leukemia - T-cell receptor | Cluster 48: Neutrophils - Phagocytosis & degranulation | Cluster 46: Brain & retina - Neuronal signaling | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in some | 4 | 3 | 2 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Pancreatic Adenocarcinoma",
"Stomach Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma",
"Stomach Adenocarcinoma"
] | 3,802 | 2 |
ENSG00000111057 | KRT18 | Keratin 18 | [
"P05783"
] | 12 | 52948871-52952906 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB000008",
"CAB000030",
"HPA001605"
] | [] | [
"Cancer-related genes",
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Cell cycle",
"Host-virus interaction"
] | [] | [
"Cancer-related genes",
"Disease variant"
] | [
"Cytosol"
] | [] | [] | [] | Supported | Enhanced | null | 95 | null | null | Cluster 46: Basophils - Proteolysis | Cluster 49: Hindbrain - Mixed function | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 13: Syncytiotrophoblasts - Placental remodeling & endocrine func. | Cluster 60: Stomach - Digestion | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enriched | Detected in many | 7 | 2 | 0 | 2 | [] | [
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 3,803 | 2 |
ENSG00000111058 | ACSS3 | Acyl-CoA synthetase short chain family member 3 | [
"Q9H6R3"
] | 12 | 80936414-81261210 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA039353",
"HPA047956",
"HPA061517"
] | [
"FLJ21963"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted membrane proteins"
] | [
"Lipid metabolism"
] | [
"Ligase"
] | [] | [
"Mitochondria"
] | [] | [] | [] | Supported | Approved | null | 2 | null | null | Cluster 46: Basophils - Proteolysis | Cluster 39: Astrocytes - Mixed function | Cluster 18: Liver cancer - Metabolism | Cluster 89: Adipocytes - Lipid metabolism | Cluster 16: Liver & Kidney - Metabolism | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in some | 15 | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Glioblastoma Multiforme"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | 3,804 | 3 |
ENSG00000111077 | TNS2 | Tensin 2 | [
"Q63HR2"
] | 12 | 53046969-53064379 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA034659"
] | [
"C1-TEN",
"KIAA1075",
"TENC1"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [] | [
"Hydrolase",
"Protein phosphatase"
] | [] | [] | [] | [] | [] | null | Approved | null | 95 | null | Yes | null | Cluster 47: Endothelial cells - Vasculature | Cluster 44: Connective tissue cells - ECM organization | Cluster 110: Mural cells - ECM organization | Cluster 74: Non-specific - Signal transduction | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 2 | 0 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 3,805 | 1 |
ENSG00000111087 | GLI1 | GLI family zinc finger 1 | [
"P08151"
] | 12 | 57459785-57472268 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB009460",
"HPA065172",
"HPA068903"
] | [
"GLI"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Differentiation",
"Transcription",
"Transcription regulation"
] | [
"Activator",
"Developmental protein",
"DNA-binding"
] | [
"Disease variant",
"Proto-oncogene"
] | [
"Nucleoplasm"
] | [
"Primary cilium tip",
"Basal body",
"Cytosol"
] | [] | [] | Supported | Uncertain | null | 38 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 19: Astrocytes - Mixed function | Cluster 38: Non-specific - Transcription | Cluster 94: Gonadal somatic cells - Mixed function | Cluster 75: Ovary - Mixed function | Tissue enhanced | Detected in many | null | Group enriched | Detected in many | 6 | Cancer enhanced | Detected in many | null | Group enriched | Detected in some | 4 | Immune cell enhanced | Detected in single | null | 0 | 0 | 0 | [] | [] | [] | 3,806 | 3 |
ENSG00000111110 | PPM1H | Protein phosphatase, Mg2+/Mn2+ dependent 1H | [
"Q9ULR3"
] | 12 | 62643994-62935150 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB020694",
"HPA044244",
"HPA058777"
] | [
"ARHCL1",
"FLJ13253",
"KIAA1157",
"NERPP-2C"
] | [
"Enzymes",
"Predicted intracellular proteins"
] | [] | [
"Hydrolase",
"Protein phosphatase"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Approved | null | 11 | null | null | Cluster 25: Non-specific - Unknown function | Cluster 35: Non-specific - DNA binding | Cluster 34: Testis cancer - Unknown function | Cluster 51: Secretory epithelial cells - Mixed function | Cluster 46: Brain & retina - Neuronal signaling | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in some | null | 1 | 0 | 1 | [
"Pancreatic Adenocarcinoma"
] | [] | [
"Pancreatic Adenocarcinoma"
] | 3,807 | 1 |
ENSG00000111142 | METAP2 | Methionyl aminopeptidase 2 | [
"P50579"
] | 12 | 95473520-95515839 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB013025",
"HPA019095"
] | [
"MAP2",
"MNPEP",
"p67"
] | [
"Enzymes",
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [
"Aminopeptidase",
"Hydrolase",
"Protease"
] | [] | [
"Plasma membrane",
"Cytosol"
] | [] | [] | [] | Supported | Enhanced | null | 142 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 28: Oligodendrocytes - Mixed function | Cluster 46: Lymphoma - Humoral immune response | Cluster 66: Erythroid cells - Erythroid differentiation and maturation | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 3,808 | 3 |
ENSG00000111144 | LTA4H | Leukotriene A4 hydrolase | [
"P09960"
] | 12 | 96000753-96043520 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA008399",
"CAB015221",
"HPA017017"
] | [] | [
"Cancer-related genes",
"Enzymes",
"Metabolic proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Leukotriene biosynthesis",
"Lipid metabolism"
] | [
"Hydrolase",
"Metalloprotease",
"Protease"
] | [
"Cancer-related genes"
] | [
"Cytosol"
] | [
"Nucleoplasm"
] | [] | [] | Supported | Supported | null | 4 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 50: Non-specific - Nucleic acid binding | Cluster 25: Non-specific - Ribosome | Cluster 37: Neutrophil progenitors - Granulopoiesis | Cluster 11: Esophagus - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 3,809 | 4 |
ENSG00000111145 | ELK3 | ETS transcription factor ELK3 | [
"P41970"
] | 12 | 96194375-96269824 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA001600"
] | [
"ERP",
"NET",
"SAP2"
] | [
"Cancer-related genes",
"Plasma proteins",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding",
"Repressor"
] | [
"Cancer-related genes"
] | [
"Nucleoplasm"
] | [
"Mitochondria"
] | [] | [] | Supported | Approved | null | 15 | null | null | Cluster 43: Non-specific - Transcription & Translation | Cluster 25: Non-specific - Transcription | Cluster 72: Neuronal - Signal transduction | Cluster 32: Endothelial cells - Angiogenesis & vascular immunity | Cluster 66: Lymphoid tissue - Immune response | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 4 | 0 | 4 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Ovary Serous Cystadenocarcinoma",
"Stomach Adenocarcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Ovary Serous Cystadenocarcinoma",
"Stomach Adenocarcinoma"
] | 3,810 | 4 |
ENSG00000111181 | SLC6A12 | Solute carrier family 6 member 12 | [
"P48065"
] | 12 | 190077-214570 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA034973"
] | [
"BGT-1"
] | [
"Metabolic proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Neurotransmitter transport",
"Symport",
"Transport"
] | [] | [] | [
"Vesicles"
] | [] | [] | [] | Approved | Approved | null | 3 | null | null | Cluster 40: Monocytes - Innate immune response | Cluster 47: Endothelial cells - Vasculature | Cluster 15: Kidney cancer - Membrane components | Cluster 22: Non-specific - Basic cellular functions | Cluster 16: Liver & Kidney - Metabolism | Group enriched | Detected in many | 7 | Group enriched | Detected in some | 5 | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in some | 43 | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 3,811 | 2 |
ENSG00000111186 | WNT5B | Wnt family member 5B | [
"Q9H1J7"
] | 12 | 1529891-1647212 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [
"HPA061991"
] | [] | [
"Predicted secreted proteins"
] | [
"Wnt signaling pathway"
] | [
"Developmental protein"
] | [] | [
"Vesicles"
] | [] | [
"Secreted to extracellular matrix"
] | [
"Developmental protein"
] | Approved | null | null | null | null | null | null | Cluster 19: Astrocytes - Mixed function | Cluster 64: Connective tissue cells - ECM organization | Cluster 44: Plasma cells - Antibody production & secretion | Cluster 38: Non-specific - Basic cellular processes | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in some | null | 1 | 0 | 1 | [
"Liver Hepatocellular Carcinoma"
] | [] | [
"Liver Hepatocellular Carcinoma"
] | 3,812 | 7 |
ENSG00000111196 | MAGOHB | Mago homolog B, exon junction complex subunit | [
"Q96A72"
] | 12 | 10604193-10613609 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA043036",
"HPA047754"
] | [
"FLJ10292",
"MGN2"
] | [
"Predicted intracellular proteins"
] | [
"mRNA processing",
"mRNA splicing",
"mRNA transport",
"Transport"
] | [
"RNA-binding"
] | [] | [] | [] | [] | [] | null | Uncertain | null | 63 | null | null | Cluster 30: Non-specific - DNA binding | Cluster 31: Non-specific - Transcription | Cluster 30: Non-specific - Gene expression regulation | Cluster 27: Non-specific - Cell proliferation | Cluster 22: Epididymis - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 5 | 0 | 5 | [
"Ovary Serous Cystadenocarcinoma",
"Stomach Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma",
"Ovary Serous Cystadenocarcinoma",
"Pancreatic Adenocarcinoma",
"Stomach Adenocarcinoma"
] | 3,813 | 7 |
ENSG00000111199 | TRPV4 | Transient receptor potential cation channel subfamily V member 4 | [
"Q9HBA0"
] | 12 | 109783087-109833406 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA007150"
] | [
"CMT2C",
"OTRPC4",
"TRP12",
"VR-OAC",
"VRL-2",
"VROAC"
] | [
"Disease related genes",
"Human disease related genes",
"Potential drug targets",
"Predicted membrane proteins",
"Voltage-gated ion channels"
] | [
"Calcium transport",
"Ion transport",
"Transport"
] | [
"Calcium channel",
"Calmodulin-binding",
"Ion channel"
] | [
"Charcot-Marie-Tooth disease",
"Disease variant",
"Dwarfism",
"Neurodegeneration",
"Neuropathy"
] | [] | [] | [] | [] | null | Uncertain | null | 2 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 36: Choroid plexus - Mixed function | Cluster 69: Skin cancer - ECM organization | Cluster 101: Choroid plexus epithelial cells - Ion transport | Cluster 1: Choroid plexus - Transmembrane transport | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 3,814 | 2 |
ENSG00000111203 | ITFG2 | Integrin alpha FG-GAP repeat containing 2 | [
"Q969R8"
] | 12 | 2812622-2859791 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA038664",
"HPA038665",
"HPA074606"
] | [
"FGGAP1",
"KICS3",
"MDS028"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Vesicles"
] | [
"Golgi apparatus"
] | [] | [] | Supported | Uncertain | null | 15 | null | No | Cluster 14: Non-specific - Unknown function | Cluster 50: Non-specific - Nucleic acid binding | Cluster 38: Non-specific - Transcription | Cluster 7: Non-specific - Transcription | Cluster 54: Non-specific - Ribosome | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 3,815 | 4 |
ENSG00000111206 | FOXM1 | Forkhead box M1 | [
"Q08050"
] | 12 | 2857680-2877174 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB017832"
] | [
"FKHL16",
"HFH-11",
"HNF-3",
"INS-1",
"MPHOSPH2",
"MPP2",
"TGT3",
"trident"
] | [
"Cancer-related genes",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Cell cycle",
"DNA damage",
"DNA repair",
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding"
] | [
"Cancer-related genes"
] | [
"Nucleoplasm",
"Nucleoli",
"Nucleoli rim"
] | [
"Cytosol"
] | [] | [] | Supported | Uncertain | null | 39 | null | Yes | null | Cluster 48: Non-specific - Mixed function | Cluster 38: Non-specific - Transcription | Cluster 27: Non-specific - Cell proliferation | Cluster 59: Lymphoid tissue & Bone marrow - Cell proliferation | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 6 | 8 | 2 | [] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 3,816 | 2 |
ENSG00000111215 | PRR4 | Proline rich 4 | [
"Q16378"
] | 12 | 10845849-10849475 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA042133"
] | [
"LPRP",
"PROL4"
] | [
"Plasma proteins",
"Predicted secreted proteins"
] | [] | [] | [] | [] | [] | [
"Secreted to digestive system"
] | [
"No annotated function"
] | null | Supported | null | 9 | null | null | null | null | Cluster 69: Skin cancer - ECM organization | Cluster 38: Secretory epithelial cells - Exocrine secretion | Cluster 82: Salivary gland - Secretion | Tissue enriched | Detected in many | 48 | Cancer enriched | Detected in single | 19 | Cancer enhanced | Detected in many | null | Cell type enriched | Detected in some | 4 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Pancreatic Adenocarcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | 3,817 | 4 |
ENSG00000111224 | PARP11 | Poly(ADP-ribose) polymerase family member 11 | [
"Q9NR21"
] | 12 | 3791047-3873448 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA026895"
] | [
"ARTD11",
"C12orf6"
] | [
"Metabolic proteins",
"Predicted intracellular proteins"
] | [
"Differentiation",
"mRNA transport",
"Protein transport",
"Spermatogenesis",
"Translocation",
"Transport"
] | [
"Glycosyltransferase",
"Nucleotidyltransferase",
"Transferase"
] | [] | [
"Nuclear bodies"
] | [
"Nucleoplasm",
"Cytosol"
] | [] | [] | Supported | Uncertain | null | 2 | null | null | Cluster 24: Non-specific - Transcription | Cluster 7: Non-specific - Ribosome | Cluster 55: Lymphoma - Immune response | Cluster 7: Non-specific - Transcription | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Pancreatic Adenocarcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | 3,819 | 5 |
ENSG00000111231 | GPN3 | GPN-loop GTPase 3 | [
"Q9UHW5"
] | 12 | 110452486-110469268 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA039764",
"HPA047793"
] | [
"ATPBD1C",
"MGC14560"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [] | [
"Hydrolase"
] | [] | [
"Nuclear speckles"
] | [
"Cytosol"
] | [] | [] | Approved | Uncertain | null | 49 | Yes | No | Cluster 29: Non-specific - Unknown function | Cluster 28: Oligodendrocytes - Mixed function | Cluster 38: Non-specific - Transcription | Cluster 53: Late primary spermatocytes - Meiotic division & transition | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 4 | 2 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | 3,821 | 4 |
ENSG00000111237 | VPS29 | VPS29 retromer complex component | [
"Q9UBQ0"
] | 12 | 110491083-110502111 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA039748"
] | [
"DC15",
"DC7",
"PEP11"
] | [
"Essential proteins",
"Metabolic proteins",
"Plasma proteins",
"Predicted intracellular proteins",
"Transporters"
] | [
"Host-virus interaction",
"Protein transport",
"Transport"
] | [] | [] | [
"Vesicles",
"Cytosol"
] | [] | [] | [] | Supported | Uncertain | null | 102 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 21: Non-specific - Metabolism | Cluster 30: Non-specific - Gene expression regulation | Cluster 97: Non-specific - Cellular respiration | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 4 | 2 | 3 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | 3,822 | 7 |
ENSG00000111241 | FGF6 | Fibroblast growth factor 6 | [
"P10767"
] | 12 | 4428155-4445815 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [] | [
"Cancer-related genes",
"Predicted intracellular proteins",
"Predicted secreted proteins",
"RAS pathway related proteins"
] | [
"Angiogenesis",
"Differentiation"
] | [
"Developmental protein",
"Growth factor",
"Mitogen"
] | [
"Cancer-related genes",
"Proto-oncogene"
] | [] | [] | [
"Secreted in other tissues"
] | [
"Growth factor"
] | null | null | null | 1 | null | null | null | Cluster 53: Neurons - Mixed function | Cluster 6: Leukemia - Signal transduction | Cluster 46: Skeletal myocytes - Muscle structure & formation | Cluster 19: Skeletal muscle - Striated muscle contraction | Group enriched | Detected in some | 21 | Cancer enriched | Detected in single | 12 | Not detected | Not detected | null | Cell type enriched | Detected in some | 14 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 3,823 | 5 |
ENSG00000111245 | MYL2 | Myosin light chain 2 | [
"P10916"
] | 12 | 110910819-110921443 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA019763",
"HPA039262"
] | [
"CMH10"
] | [
"Candidate cardiovascular disease genes",
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [] | [
"Motor protein",
"Muscle protein",
"Myosin"
] | [
"Cardiomyopathy",
"Disease variant",
"Myofibrillar myopathy"
] | [
"Microtubules"
] | [] | [] | [] | Uncertain | Supported | null | 9 | null | null | null | Cluster 45: Non-specific - Mixed function | Cluster 72: Neuronal - Signal transduction | Cluster 55: Myocytes - Oxidative muscle function | Cluster 41: Striated muscle - Muscle contraction | Group enriched | Detected in many | 73 | Cancer enriched | Detected in some | 12 | Group enriched | Detected in some | 41 | Group enriched | Detected in some | 4 | Group enriched | Detected in some | 12 | 0 | 0 | 0 | [] | [] | [] | 3,824 | 8 |
ENSG00000111249 | CUX2 | Cut like homeobox 2 | [
"O14529"
] | 12 | 111034165-111350554 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"CDP2",
"CUTL2",
"KIAA0293"
] | [
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"DNA-binding"
] | [
"Disease variant",
"Epilepsy"
] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 44: Plasmacytoid DCs - Plasma membrane proteins | Cluster 53: Neurons - Mixed function | Cluster 46: Lymphoma - Humoral immune response | Cluster 16: Prostatic glandular cells - Androgen response & seminal fluid | Cluster 36: Brain & Liver - Signaling | Tissue enhanced | Detected in some | null | Cancer enhanced | Detected in some | null | Cancer enhanced | Detected in some | null | Group enriched | Detected in many | 4 | Immune cell enriched | Detected in single | 70 | 2 | 0 | 2 | [
"Glioblastoma Multiforme",
"Liver Hepatocellular Carcinoma"
] | [] | [
"Glioblastoma Multiforme",
"Liver Hepatocellular Carcinoma"
] | 3,826 | 1 |
ENSG00000111252 | SH2B3 | SH2B adaptor protein 3 | [
"Q9UQQ2"
] | 12 | 111405923-111451623 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA005483"
] | [
"IDDM20",
"LNK"
] | [
"Cancer-related genes",
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [] | [] | [
"Cancer-related genes",
"Diabetes mellitus"
] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Approved | null | 6 | null | null | Cluster 10: Non-specific - Membrane trafficking | Cluster 20: Macrophages & Microglia - Immune response | Cluster 72: Neuronal - Signal transduction | Cluster 6: Plasmacytoid dendritic cells - Viral sensing & interferon response | Cluster 29: Lymphoid tissue & Bone marrow - Innate immune response | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 3,827 | 6 |
ENSG00000111254 | AKAP3 | A-kinase anchoring protein 3 | [
"O75969"
] | 12 | 4615508-4649051 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA039765",
"HPA073296"
] | [
"AKAP110",
"CT82",
"FSP95",
"SOB1"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Vesicles"
] | [
"Cytosol",
"Principal piece"
] | [] | [] | Approved | Enhanced | null | 10 | null | null | Cluster 24: Non-specific - Transcription | Cluster 13: Oligodendrocytes - Mixed function | Cluster 38: Non-specific - Transcription | Cluster 33: Early spermatids - Spermiogenesis: Cap phase | Cluster 6: Testis - Spermatogenesis | Tissue enriched | Detected in some | 23 | Group enriched | Detected in some | 5 | Cancer enriched | Detected in some | 7 | Group enriched | Detected in many | 43 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 3,828 | 7 |
ENSG00000111261 | MANSC1 | MANSC domain containing 1 | [
"Q9H8J5"
] | 12 | 12326056-12350242 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA007955",
"HPA007956"
] | [
"FLJ10298",
"LOH12CR3"
] | [
"Metabolic proteins",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [] | [] | [
"Vesicles"
] | [
"Golgi apparatus"
] | [] | [] | Approved | Approved | null | 5 | null | null | Cluster 4: Neutrophils - Degranulation | Cluster 23: Choroid plexus - Mixed function | Cluster 57: Stomach & Colon cancer - Digestion | Cluster 98: Neurons - Neurotransmission & signaling | Cluster 60: Stomach - Digestion | Tissue enhanced | Detected in all | null | Cancer enriched | Detected in many | 6 | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in some | null | Immune cell enriched | Detected in some | 15 | 2 | 0 | 2 | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 3,829 | 7 |
ENSG00000111262 | KCNA1 | Potassium voltage-gated channel subfamily A member 1 | [
"Q09470"
] | 12 | 4909905-4918256 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA074471"
] | [
"AEMK",
"HUK1",
"Kv1.1",
"MBK1",
"RBK1"
] | [
"Disease related genes",
"FDA approved drug targets",
"Human disease related genes",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters",
"Voltage-gated ion channels"
] | [
"Ion transport",
"Potassium transport",
"Transport"
] | [
"Ion channel",
"Potassium channel",
"Voltage-gated channel"
] | [
"Disease variant",
"FDA approved drug targets"
] | [] | [] | [] | [] | null | Approved | null | 18 | null | null | null | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 10: Ciliated cells - Ion channel activity | Cluster 2: Cerebellar granular cells - Neuronal signaling | Cluster 27: Cerebellum - Synaptic function | Tissue enriched | Detected in some | 40 | Cancer enriched | Detected in single | 5 | Not detected | Not detected | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 3,830 | 9 |
ENSG00000111266 | DUSP16 | Dual specificity phosphatase 16 | [
"Q9BY84"
] | 12 | 12473282-12562863 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA020326"
] | [
"KIAA1700",
"MKP-7",
"MKP7"
] | [
"Enzymes",
"Predicted intracellular proteins"
] | [] | [
"Hydrolase",
"Protein phosphatase"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Approved | null | 17 | null | null | Cluster 9: T-regs - Cell cycle regulation | Cluster 11: White matter - Signal transduction | Cluster 38: Non-specific - Transcription | Cluster 102: Non-specific - Mixed function | Cluster 76: Non-specific - Metabolism | Low tissue specificity | Detected in all | null | Cancer enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in some | null | 2 | 0 | 2 | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 3,831 | 6 |
ENSG00000111269 | CREBL2 | CAMP responsive element binding protein like 2 | [
"O60519"
] | 12 | 12611827-12645108 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA043738"
] | [] | [
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Cell cycle",
"Differentiation",
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding"
] | [
"Tumor suppressor"
] | [
"Mitochondria"
] | [
"Nucleoplasm",
"Cytosol"
] | [] | [] | Approved | Uncertain | null | 6 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 14: Neurons - Synaptic function | Cluster 38: Non-specific - Transcription | Cluster 72: Macrophages - Phagocytosis & lysosomal degradation | Cluster 4: Adrenal gland - Steroid metabolism | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 1 | 2 | 0 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 3,832 | 3 |
ENSG00000111275 | ALDH2 | Aldehyde dehydrogenase 2 family member | [
"P05091"
] | 12 | 111766887-111817532 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA051065"
] | [] | [
"Disease related genes",
"Enzymes",
"FDA approved drug targets",
"Human disease related genes",
"Metabolic proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [
"Oxidoreductase"
] | [
"Disease variant",
"Dwarfism",
"FDA approved drug targets",
"Intellectual disability"
] | [] | [] | [] | [] | null | Approved | null | 12 | null | null | Cluster 10: Non-specific - Membrane trafficking | Cluster 19: Astrocytes - Mixed function | Cluster 57: Stomach & Colon cancer - Digestion | Cluster 72: Macrophages - Phagocytosis & lysosomal degradation | Cluster 16: Liver & Kidney - Metabolism | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 4 | 2 | 3 | [
"Colon Adenocarcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | [] | [
"Colon Adenocarcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | 3,834 | 9 |
ENSG00000111276 | CDKN1B | Cyclin dependent kinase inhibitor 1B | [
"P46527"
] | 12 | 12685498-12722369 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB003691",
"CAB021888",
"HPA064413"
] | [
"KIP1",
"P27KIP1"
] | [
"Cancer-related genes",
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Cell cycle"
] | [
"Protein kinase inhibitor"
] | [
"Cancer-related genes",
"Tumor suppressor"
] | [
"Nucleoplasm",
"Centrosome"
] | [
"Primary cilium",
"Primary cilium transition zone",
"Basal body",
"Cytosol"
] | [] | [] | Supported | Approved | null | 134 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 28: Oligodendrocytes - Mixed function | Cluster 51: Myeloma - Immunoglobulins | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 65: Brain - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 3,835 | 3 |
ENSG00000111291 | GPRC5D | G protein-coupled receptor class C group 5 member D | [
"Q9NZD1"
] | 12 | 12940575-12952170 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA071909"
] | [] | [
"G-protein coupled receptors",
"Predicted membrane proteins"
] | [] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [] | [] | [] | [] | [] | null | Approved | null | 24 | null | null | Cluster 23: B-cells - Immunoglobulins | Cluster 44: Non-specific - Mixed function | Cluster 51: Myeloma - Immunoglobulins | Cluster 103: Non-specific - Basic cellular processes | Cluster 9: Skin - Hair follicle development | Tissue enriched | Detected in some | 6 | Cancer enriched | Detected in many | 20 | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in some | 10 | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 3,836 | 1 |
ENSG00000111300 | NAA25 | N-alpha-acetyltransferase 25, NatB auxiliary subunit | [
"Q14CX7"
] | 12 | 112026689-112108796 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA039322"
] | [
"C12orf30",
"FLJ13089"
] | [
"Essential proteins",
"Human disease related genes",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [] | [] | [
"Golgi apparatus",
"Cytosol"
] | [] | [] | [] | Supported | Approved | null | 3 | No | No | Cluster 30: Non-specific - DNA binding | Cluster 34: Non-specific - Mixed function | Cluster 38: Non-specific - Transcription | Cluster 99: Retinal pigment epithelial cells - Retinol metabolism | Cluster 25: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 2 | 0 | 2 | [
"Rectum Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Rectum Adenocarcinoma"
] | 3,837 | 4 |
ENSG00000111305 | GSG1 | Germ cell associated 1 | [
"Q2KHT4"
] | 12 | 13083532-13103683 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"MGC3146"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters"
] | [] | [] | [] | [] | [] | [] | [] | null | null | null | 1 | null | null | null | Cluster 9: Non-specific - Receptor signaling | Cluster 5: Rhabdoid - Unknown function | Cluster 56: Late spermatids - Spermiogenesis: Maturation | Cluster 47: Testis - Mixed function | Tissue enriched | Detected in some | 14 | Cancer enriched | Detected in some | 13 | Group enriched | Detected in some | 5 | Cell type enriched | Detected in some | 7 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | 3,838 | 5 |
ENSG00000111319 | SCNN1A | Sodium channel epithelial 1 subunit alpha | [
"P37088"
] | 12 | 6346843-6377730 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA012743"
] | [
"ENaCalpha",
"SCNN1"
] | [
"Disease related genes",
"FDA approved drug targets",
"Human disease related genes",
"Metabolic proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Ion transport",
"Sodium transport",
"Transport"
] | [
"Ion channel",
"Sodium channel"
] | [
"Disease variant",
"FDA approved drug targets"
] | [
"Vesicles",
"Annulus"
] | [
"Acrosome"
] | [] | [] | Uncertain | Enhanced | null | 10 | null | null | null | Cluster 36: Choroid plexus - Mixed function | Cluster 10: Ciliated cells - Ion channel activity | Cluster 38: Secretory epithelial cells - Exocrine secretion | Cluster 11: Esophagus - Basic cellular processes | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in some | null | 1 | 2 | 0 | [] | [
"Pancreatic Adenocarcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | 3,839 | 6 |
ENSG00000111321 | LTBR | Lymphotoxin beta receptor | [
"P36941"
] | 12 | 6375045-6391571 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB026202",
"HPA061617"
] | [
"D12S370",
"TNF-R-III",
"TNFCR",
"TNFR-RP",
"TNFR2-RP",
"TNFRSF3"
] | [
"Cancer-related genes",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Apoptosis",
"Host-virus interaction"
] | [
"Receptor"
] | [
"Cancer-related genes"
] | [
"Golgi apparatus"
] | [] | [] | [] | Supported | Uncertain | null | 22 | null | Yes | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 20: Macrophages & Microglia - Immune response | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 17: Non-specific - RNA processing | Cluster 11: Esophagus - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in many | 5 | 1 | 2 | 0 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 3,840 | 7 |
ENSG00000111325 | OGFOD2 | 2-oxoglutarate and iron dependent oxygenase domain containing 2 | [
"Q6N063"
] | 12 | 122974580-122980043 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA039448",
"HPA040306"
] | [
"FLJ13491",
"FLJ37501"
] | [
"Predicted intracellular proteins"
] | [] | [
"Dioxygenase",
"Oxidoreductase"
] | [] | [
"Nucleoplasm"
] | [
"Nuclear bodies"
] | [] | [] | Supported | Approved | null | null | null | null | Cluster 25: Non-specific - Unknown function | Cluster 6: Non-specific - Immune response | Cluster 38: Non-specific - Transcription | Cluster 10: Epididymal principal cells - Sperm maturation microenvironment | Cluster 21: Testis - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in some | null | Low immune cell specificity | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 3,841 | 2 |
ENSG00000111328 | CDK2AP1 | Cyclin dependent kinase 2 associated protein 1 | [
"O14519"
] | 12 | 123250112-123272334 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB019377",
"HPA057648",
"HPA068833"
] | [
"doc-1",
"DOC1",
"DORC1",
"p12DOC-1",
"ST19"
] | [
"Predicted intracellular proteins"
] | [
"Cell cycle",
"Transcription",
"Transcription regulation"
] | [] | [
"Tumor suppressor"
] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Enhanced | Approved | null | 49 | null | null | Cluster 37: Monocytes & Neutrophils - Innate immune response | Cluster 19: Astrocytes - Mixed function | Cluster 69: Skin cancer - ECM organization | Cluster 47: Platelets - Hemostasis | Cluster 3: Oligodendrocytes - Myelination | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in many | 5 | 2 | 0 | 2 | [] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma"
] | 3,842 | 2 |
ENSG00000111331 | OAS3 | 2'-5'-oligoadenylate synthetase 3 | [
"Q9Y6K5"
] | 12 | 112938051-112976460 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA041253",
"HPA041372"
] | [] | [
"Enzymes",
"Predicted intracellular proteins"
] | [
"Antiviral defense",
"Immunity",
"Innate immunity"
] | [
"Nucleotidyltransferase",
"RNA-binding",
"Transferase"
] | [] | [
"Nucleoplasm",
"Cytosol"
] | [
"Plasma membrane"
] | [] | [] | Supported | Uncertain | null | 18 | Yes | No | Cluster 37: Monocytes & Neutrophils - Innate immune response | Cluster 43: Hindbrain - Mixed function | Cluster 31: Non-specific - Antiviral immune response | Cluster 32: Endothelial cells - Angiogenesis & vascular immunity | Cluster 29: Lymphoid tissue & Bone marrow - Innate immune response | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 1 | 0 | 1 | [] | [
"Pancreatic Adenocarcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | 3,843 | 5 |
ENSG00000111335 | OAS2 | 2'-5'-oligoadenylate synthetase 2 | [
"P29728"
] | 12 | 112978395-113011723 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA003320",
"CAB024984"
] | [] | [
"Enzymes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Antiviral defense",
"Immunity",
"Innate immunity"
] | [
"Nucleotidyltransferase",
"RNA-binding",
"Transferase"
] | [] | [
"Centrosome"
] | [] | [] | [] | Approved | Approved | null | 3 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 43: Hindbrain - Mixed function | Cluster 31: Non-specific - Antiviral immune response | Cluster 72: Macrophages - Phagocytosis & lysosomal degradation | Cluster 66: Lymphoid tissue - Immune response | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Pancreatic Adenocarcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | 3,844 | 2 |
ENSG00000111341 | MGP | Matrix Gla protein | [
"P08493"
] | 12 | 14880864-14885857 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA013949"
] | [] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [
"Chondrogenesis",
"Differentiation",
"Osteogenesis"
] | [
"Developmental protein"
] | [
"Deafness"
] | [] | [] | [
"Secreted to blood"
] | [
"Developmental protein"
] | null | Approved | null | 1 | null | null | Cluster 8: Plasmacytoid DCs - Unknown function | Cluster 8: Immune cells - Immune response | Cluster 5: Rhabdoid - Unknown function | Cluster 108: Fibroblasts - ECM organization | Cluster 12: Smooth muscle tissue - ECM organization | Tissue enriched | Detected in all | 4 | Group enriched | Detected in many | 4 | Cancer enriched | Detected in all | 5 | Cell type enhanced | Detected in many | null | Immune cell enriched | Detected in single | 9 | 1 | 0 | 1 | [] | [
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma"
] | 3,846 | 7 |
ENSG00000111344 | RASAL1 | RAS protein activator like 1 | [
"O95294"
] | 12 | 113098819-113136239 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA041650"
] | [
"RASAL"
] | [
"Plasma proteins",
"Predicted intracellular proteins",
"RAS pathway related proteins"
] | [
"Differentiation"
] | [
"GTPase activation"
] | [] | [
"Plasma membrane",
"Cytosol"
] | [
"Cell Junctions"
] | [] | [] | Approved | Enhanced | null | null | null | null | null | Cluster 34: Non-specific - Mixed function | Cluster 46: Lymphoma - Humoral immune response | Cluster 64: Renal epithelial cells - Ion transport & homeostasis | Cluster 69: Parathyroid gland - Mixed function | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Ovary Serous Cystadenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | 3,847 | 2 |
ENSG00000111348 | ARHGDIB | Rho GDP dissociation inhibitor beta | [
"P52566"
] | 12 | 14942031-14961728 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB018584",
"HPA051235"
] | [
"GDIA2",
"GDID4",
"Ly-GDI",
"RAP1GN1",
"RhoGDI2"
] | [
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [
"GTPase activation"
] | [] | [
"Cytosol"
] | [] | [] | [] | Supported | Enhanced | null | 9 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 20: Macrophages & Microglia - Immune response | Cluster 59: Leukemia - T-cell receptor | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 51: Lymphoid tissue - Adaptive immune response | Group enriched | Detected in all | 5 | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 3,848 | 5 |
ENSG00000111358 | GTF2H3 | General transcription factor IIH subunit 3 | [
"Q13889"
] | 12 | 123633739-123662604 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA004844",
"HPA053562"
] | [
"BTF2",
"P34",
"TFIIH"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [
"DNA damage",
"DNA repair",
"Transcription",
"Transcription regulation"
] | [] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Uncertain | null | 27 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 30: White matter - Myelination | Cluster 38: Non-specific - Transcription | Cluster 17: Non-specific - RNA processing | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in many | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma",
"Rectum Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Rectum Adenocarcinoma"
] | 3,849 | 7 |
ENSG00000111361 | EIF2B1 | Eukaryotic translation initiation factor 2B subunit alpha | [
"Q14232"
] | 12 | 123620406-123633766 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB034258",
"HPA049509"
] | [
"EIF-2B",
"EIF-2Balpha",
"EIF2B",
"EIF2BA",
"EIF2Balpha"
] | [
"Disease related genes",
"Essential proteins",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Protein biosynthesis"
] | [
"Initiation factor"
] | [
"Disease variant",
"Leukodystrophy"
] | [
"Cytosol"
] | [] | [] | [] | Approved | Approved | null | 46 | null | null | Cluster 25: Non-specific - Unknown function | Cluster 28: Oligodendrocytes - Mixed function | Cluster 38: Non-specific - Transcription | Cluster 63: Cytotrophoblasts - Basic cellular functions | Cluster 49: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 3,850 | 5 |
ENSG00000111364 | DDX55 | DEAD-box helicase 55 | [
"Q8NHQ9"
] | 12 | 123602077-123620943 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA039962",
"HPA044101"
] | [
"KIAA1595"
] | [
"Enzymes",
"Essential proteins",
"Predicted intracellular proteins"
] | [
"Ribosome biogenesis",
"rRNA processing"
] | [
"Helicase",
"Hydrolase",
"RNA-binding",
"rRNA-binding"
] | [] | [
"Nucleoli"
] | [
"Nucleoplasm",
"Cytosol"
] | [] | [] | Enhanced | Approved | null | 24 | null | null | Cluster 30: Non-specific - DNA binding | Cluster 6: Non-specific - Immune response | Cluster 38: Non-specific - Transcription | Cluster 17: Non-specific - RNA processing | Cluster 15: Bone marrow - Innate immune response | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma",
"Prostate Adenocarcinoma"
] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma",
"Prostate Adenocarcinoma"
] | 3,851 | 6 |
ENSG00000111371 | SLC38A1 | Solute carrier family 38 member 1 | [
"Q9H2H9"
] | 12 | 46183063-46270017 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA039460",
"HPA052272"
] | [
"ATA1",
"NAT2",
"SAT1"
] | [
"FDA approved drug targets",
"Metabolic proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Amino-acid transport",
"Ion transport",
"Sodium transport",
"Symport",
"Transport"
] | [] | [
"FDA approved drug targets"
] | [] | [] | [] | [] | null | Uncertain | Supported | 41 | null | null | Cluster 24: Non-specific - Transcription | Cluster 25: Non-specific - Transcription | Cluster 38: Non-specific - Transcription | Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 3,852 | 4 |
ENSG00000111404 | RERGL | RERG like | [
"Q9H628"
] | 12 | 18080869-18320107 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | [
"HPA041740"
] | [
"FLJ22655"
] | [
"Enzymes",
"Predicted intracellular proteins"
] | [] | [
"Hydrolase"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Uncertain | null | null | null | null | null | Cluster 47: Endothelial cells - Vasculature | Cluster 5: Rhabdoid - Unknown function | Cluster 62: Smooth muscle cells - Muscle contraction | Cluster 12: Smooth muscle tissue - ECM organization | Tissue enriched | Detected in many | 4 | Cancer enhanced | Detected in some | null | Cancer enhanced | Detected in many | null | Cell type enriched | Detected in many | 18 | Not detected in immune cells | Not detected | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 3,853 | 4 |
ENSG00000111405 | ENDOU | Endonuclease, poly(U) specific | [
"P21128"
] | 12 | 47709734-47725567 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA012388",
"HPA067448"
] | [
"P11",
"PP11",
"PRSS26"
] | [
"Predicted secreted proteins"
] | [] | [
"Endonuclease",
"Hydrolase",
"Lyase",
"Nuclease",
"RNA-binding"
] | [] | [] | [] | [
"Secreted in other tissues"
] | [
"Enzyme"
] | null | Enhanced | null | null | null | null | null | Cluster 19: Astrocytes - Mixed function | Cluster 15: Kidney cancer - Membrane components | Cluster 49: Apical squamous epithelium - Epithelial barrier & keratinization | Cluster 81: Squamous epithelium - Keratinization | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in some | null | Cancer enhanced | Detected in some | null | Cell type enriched | Detected in some | 4 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Head and Neck Squamous Cell Carcinoma"
] | [] | [
"Head and Neck Squamous Cell Carcinoma"
] | 3,854 | 2 |
ENSG00000111412 | SPRING1 | SREBF pathway regulator in golgi 1 | [
"Q9H741"
] | 12 | 116710171-116738070 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA026905"
] | [
"C12orf49",
"FLJ21415",
"LUR1",
"POST1",
"SPRING"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | Uncertain | null | 27 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 45: Non-specific - Mixed function | Cluster 46: Lymphoma - Humoral immune response | Cluster 51: Secretory epithelial cells - Mixed function | Cluster 33: Thyroid gland - Tissue development | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 3,855 | 9 |
ENSG00000111424 | VDR | Vitamin D receptor | [
"P11473"
] | 12 | 47841537-47943048 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB004617",
"HPA047740",
"HPA072102"
] | [
"NR1I1",
"PPP1R163"
] | [
"Disease related genes",
"FDA approved drug targets",
"Human disease related genes",
"Nuclear receptors",
"Predicted intracellular proteins",
"Transcription factors",
"Transporters"
] | [
"Transcription",
"Transcription regulation"
] | [
"DNA-binding",
"Receptor"
] | [
"Disease variant",
"FDA approved drug targets"
] | [
"Nucleoplasm"
] | [
"Intermediate filaments",
"Cytosol"
] | [] | [] | Supported | null | null | 61 | null | null | Cluster 40: Monocytes - Innate immune response | Cluster 12: Non-specific - Vasculature | Cluster 57: Stomach & Colon cancer - Digestion | Cluster 54: Intestinal epithelial cells - Intestinal epi homeostasis & respiration | Cluster 69: Parathyroid gland - Mixed function | Tissue enriched | Detected in many | 4 | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in many | 7 | 3 | 0 | 3 | [
"Bladder Urothelial Carcinoma"
] | [
"Glioblastoma Multiforme",
"Lung Adenocarcinoma"
] | [
"Bladder Urothelial Carcinoma",
"Glioblastoma Multiforme",
"Lung Adenocarcinoma"
] | 3,856 | 8 |
ENSG00000111432 | FZD10 | Frizzled class receptor 10 | [
"Q9ULW2"
] | 12 | 130162459-130165740 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA014484",
"HPA014485"
] | [
"CD350"
] | [
"CD markers",
"G-protein coupled receptors",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Wnt signaling pathway"
] | [
"Developmental protein",
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Uncertain | null | 6 | null | null | null | Cluster 19: Astrocytes - Mixed function | Cluster 7: Liver cancer - Metabolism | Cluster 17: Non-specific - RNA processing | Cluster 81: Squamous epithelium - Keratinization | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in some | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 3,857 | 3 |
ENSG00000111445 | RFC5 | Replication factor C subunit 5 | [
"P40937"
] | 12 | 118013588-118033130 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA041037"
] | [
"RFC36"
] | [
"Essential proteins",
"Metabolic proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"DNA replication"
] | [] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Supported | null | 80 | null | null | Cluster 16: Non-specific - Cell proliferation | Cluster 31: Non-specific - Transcription | Cluster 38: Non-specific - Transcription | Cluster 27: Non-specific - Cell proliferation | Cluster 44: Bone marrow - Nuclear processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 3,858 | 9 |
ENSG00000111450 | STX2 | Syntaxin 2 | [
"P32856"
] | 12 | 130789600-130839254 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA069176",
"CAB079007"
] | [
"EPIM",
"EPM",
"STX2A",
"STX2B",
"STX2C"
] | [
"Cancer-related genes",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [] | [
"Cancer-related genes"
] | [
"Vesicles"
] | [
"Nuclear membrane"
] | [] | [] | Approved | Uncertain | Supported | 9 | null | null | null | Cluster 21: Non-specific - Metabolism | Cluster 64: Connective tissue cells - ECM organization | Cluster 101: Choroid plexus epithelial cells - Ion transport | Cluster 74: Non-specific - Signal transduction | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Lung Adenocarcinoma"
] | [
"Lung Adenocarcinoma"
] | 3,859 | 9 |
ENSG00000111452 | ADGRD1 | Adhesion G protein-coupled receptor D1 | [
"Q6QNK2"
] | 12 | 130953907-131141469 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA042395",
"HPA076279"
] | [
"DKFZp434B1272",
"GPR133",
"PGR25"
] | [
"G-protein coupled receptors",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [] | [
"Plasma membrane"
] | [
"Nucleoplasm",
"Nuclear speckles"
] | [] | [] | Approved | Uncertain | null | 1 | null | null | Cluster 26: Monocytes - Plasma membrane proteins | Cluster 38: Sub-cortical - Mixed function | Cluster 64: Connective tissue cells - ECM organization | Cluster 108: Fibroblasts - ECM organization | Cluster 14: Adipose tissue - Angiogenesis | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in some | 6 | 2 | 0 | 2 | [
"Lung Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 3,860 | 6 |
ENSG00000111481 | COPZ1 | COPI coat complex subunit zeta 1 | [
"P61923"
] | 12 | 54301202-54351846 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"CGI-120",
"COPZ"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [
"ER-Golgi transport",
"Protein transport",
"Transport"
] | [] | [] | [] | [] | [] | [] | null | null | null | 70 | null | null | Cluster 10: Non-specific - Membrane trafficking | Cluster 21: Non-specific - Metabolism | Cluster 38: Non-specific - Transcription | Cluster 8: Non-specific - Secretory pathway | Cluster 38: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [
"Uterine Corpus Endometrial Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Uterine Corpus Endometrial Carcinoma"
] | 3,861 | 4 |
ENSG00000111490 | TBC1D30 | TBC1 domain family member 30 | [
"Q9Y2I9"
] | 12 | 64759484-64881033 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA039772",
"HPA040043"
] | [
"KIAA0984"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [] | [] | [
"Plasma membrane"
] | [
"Mid piece",
"Principal piece"
] | [] | [] | Supported | Approved | null | 1 | null | null | null | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 17: Neuroblastoma - Neuronal signaling | Cluster 101: Choroid plexus epithelial cells - Ion transport | Cluster 70: Non-specific - Protein processing | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 2 | 0 | 2 | [
"Colon Adenocarcinoma",
"Glioblastoma Multiforme"
] | [] | [
"Colon Adenocarcinoma",
"Glioblastoma Multiforme"
] | 3,862 | 2 |
ENSG00000111536 | IL26 | Interleukin 26 | [
"Q9NPH9"
] | 12 | 68201349-68225810 | Evidence at protein level | No human protein/transcript evidence | Evidence at protein level | Evidence at protein level | [
"HPA077990"
] | [
"AK155",
"IL-26"
] | [
"Plasma proteins",
"Predicted secreted proteins"
] | [] | [
"Cytokine"
] | [] | [
"Golgi apparatus",
"Vesicles"
] | [] | [
"Secreted to blood"
] | [
"Interleukin"
] | Approved | null | null | null | null | null | null | null | Cluster 71: Lymphoma - Inflammatory response | Cluster 9: T-cells - Adaptive immunity: Regulation | null | Not detected | Not detected | null | Cancer enriched | Detected in some | 17 | Not detected | Not detected | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 3,864 | 1 |
ENSG00000111537 | IFNG | Interferon gamma | [
"P01579"
] | 12 | 68154768-68159740 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"CAB010344"
] | [] | [
"Cancer-related genes",
"Disease related genes",
"FDA approved drug targets",
"Human disease related genes",
"Plasma proteins",
"Predicted secreted proteins"
] | [
"Antiviral defense",
"Growth regulation"
] | [
"Cytokine"
] | [
"Cancer-related genes",
"FDA approved drug targets"
] | [] | [] | [
"Secreted to blood"
] | [
"Interferon"
] | null | Approved | null | 11 | null | null | Cluster 24: Non-specific - Transcription | null | Cluster 59: Leukemia - T-cell receptor | Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity | Cluster 15: Bone marrow - Innate immune response | Group enriched | Detected in some | 5 | Not detected | Not detected | null | Low cancer specificity | Detected in some | null | Group enriched | Detected in some | 5 | Group enriched | Detected in some | 5 | 0 | 0 | 0 | [] | [] | [] | 3,865 | 8 |
ENSG00000111554 | MDM1 | Mdm1 nuclear protein | [
"Q8TC05"
] | 12 | 68272443-68332381 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA040411",
"HPA041594"
] | [] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [] | [] | [
"Centriolar satellite",
"Cytosol"
] | [] | [] | [] | Approved | Uncertain | null | 3 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 3: Choroid plexus - Cilium | Cluster 5: Rhabdoid - Unknown function | Cluster 37: Neutrophil progenitors - Granulopoiesis | Cluster 48: Ciliated tissues - Cilium organization | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Kidney Chromophobe"
] | [
"Kidney Chromophobe"
] | 3,867 | 7 |
ENSG00000111581 | NUP107 | Nucleoporin 107 | [
"P57740"
] | 12 | 68686951-68745809 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA031679"
] | [
"NUP84"
] | [
"Disease related genes",
"Essential proteins",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins",
"Transporters"
] | [
"mRNA transport",
"Protein transport",
"Translocation",
"Transport"
] | [] | [
"Disease variant",
"Epilepsy",
"Intellectual disability"
] | [
"Nucleoplasm"
] | [
"Nuclear membrane",
"Centrosome"
] | [] | [] | Uncertain | null | null | 57 | null | null | Cluster 3: Non-specific - Nuclear processes | Cluster 55: Non-specific - Transcription | Cluster 38: Non-specific - Transcription | Cluster 27: Non-specific - Cell proliferation | Cluster 39: Testis - Nuclear processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 3,868 | 7 |
ENSG00000111596 | CNOT2 | CCR4-NOT transcription complex subunit 2 | [
"Q9NZN8"
] | 12 | 70243002-70354993 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA067711"
] | [
"CDC36",
"NOT2",
"NOT2H"
] | [
"Disease related genes",
"Essential proteins",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"RNA-mediated gene silencing",
"Transcription",
"Transcription regulation",
"Translation regulation"
] | [
"Developmental protein",
"Repressor"
] | [
"Disease variant",
"Intellectual disability"
] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Approved | Approved | null | 79 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 25: Non-specific - Transcription | Cluster 38: Non-specific - Transcription | Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity | Cluster 49: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 4 | 0 | 4 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | 3,869 | 1 |
ENSG00000111602 | TIMELESS | Timeless circadian regulator | [
"Q9UNS1"
] | 12 | 56416363-56449426 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA060655"
] | [
"hTIM",
"TIM",
"TIM1"
] | [
"Disease related genes",
"Essential proteins",
"Predicted intracellular proteins"
] | [
"Biological rhythms",
"Cell cycle",
"Cell division",
"DNA damage",
"DNA repair",
"Mitosis",
"Transcription",
"Transcription regulation"
] | [
"Developmental protein"
] | [
"Disease variant"
] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Enhanced | null | 17 | No | No | Cluster 14: Non-specific - Unknown function | Cluster 26: Oligodendrocytes - Mixed function | Cluster 38: Non-specific - Transcription | Cluster 86: Retinal bipolar cells - Synaptic signal transduction | Cluster 59: Lymphoid tissue & Bone marrow - Cell proliferation | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 4 | 2 | 3 | [] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Skin Cutaneous Melanoma"
] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Skin Cutaneous Melanoma"
] | 3,870 | 2 |
ENSG00000111605 | CPSF6 | Cleavage and polyadenylation specific factor 6 | [
"Q16630"
] | 12 | 69239569-69274358 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA039973"
] | [
"CFIM",
"CFIM68",
"CFIM72",
"HPBRII-4",
"HPBRII-7"
] | [
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"mRNA processing"
] | [
"RNA-binding"
] | [] | [
"Nucleoplasm",
"Nuclear speckles"
] | [] | [] | [] | Enhanced | Supported | null | 318 | No | No | Cluster 12: Non-specific - Mitochondrial translation | Cluster 15: Non-specific - Transcription | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 17: Non-specific - RNA processing | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 4 | 0 | 4 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 3,871 | 6 |
ENSG00000111615 | KRR1 | KRR1 small subunit processome component homolog | [
"Q13601"
] | 12 | 75490863-75511636 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA043433",
"HPA051690"
] | [
"HRB2",
"RIP-1"
] | [
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Ribosome biogenesis",
"rRNA processing"
] | [
"Ribonucleoprotein",
"RNA-binding"
] | [] | [
"Nucleoli",
"Nucleoli rim"
] | [
"Nucleoplasm",
"Mitotic chromosome"
] | [] | [] | Enhanced | Approved | null | 147 | Yes | No | Cluster 3: Non-specific - Nuclear processes | Cluster 31: Non-specific - Transcription | Cluster 5: Rhabdoid - Unknown function | Cluster 71: Non-specific - Cardiac endocrine signaling & maintenanc | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 3,872 | 6 |
ENSG00000111639 | MRPL51 | Mitochondrial ribosomal protein L51 | [
"Q4U2R6"
] | 12 | 6491886-6493841 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA039923"
] | [
"bMRP64",
"CDA09",
"HSPC241",
"MRP64"
] | [
"Essential proteins",
"Predicted intracellular proteins",
"Ribosomal proteins"
] | [] | [
"Ribonucleoprotein",
"Ribosomal protein"
] | [] | [
"Mitochondria"
] | [
"Nucleoli"
] | [] | [] | Supported | Approved | null | 96 | null | null | Cluster 22: Eosinophils - Transcription | Cluster 27: Non-specific - Mixed function | Cluster 38: Non-specific - Transcription | Cluster 97: Non-specific - Cellular respiration | Cluster 68: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [
"Breast Invasive Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Breast Invasive Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 3,873 | 4 |
ENSG00000111641 | NOP2 | NOP2 nucleolar protein | [
"P46087"
] | 12 | 6556863-6568691 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA040119"
] | [
"NOL1",
"NOP120",
"NSUN1",
"p120"
] | [
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Ribosome biogenesis",
"rRNA processing"
] | [
"Methyltransferase",
"RNA-binding",
"Transferase"
] | [] | [
"Nucleoli"
] | [] | [] | [] | Enhanced | Supported | null | 78 | No | No | Cluster 33: Non-specific - ATP binding | Cluster 48: Non-specific - Mixed function | Cluster 38: Non-specific - Transcription | Cluster 98: Neurons - Neurotransmission & signaling | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 4 | 0 | 4 | [
"Glioblastoma Multiforme"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 3,875 | 3 |
ENSG00000111642 | CHD4 | Chromodomain helicase DNA binding protein 4 | [
"Q14839"
] | 12 | 6570082-6614524 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA012008"
] | [
"Mi-2b",
"Mi2-BETA"
] | [
"Cancer-related genes",
"Disease related genes",
"Enzymes",
"Essential proteins",
"Human disease related genes",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Transcription",
"Transcription regulation"
] | [
"Chromatin regulator",
"DNA-binding",
"Hydrolase"
] | [
"Cancer-related genes",
"Disease variant",
"Intellectual disability"
] | [
"Nucleoplasm"
] | [
"Mitotic spindle",
"Cytosol"
] | [] | [] | Enhanced | Supported | null | 221 | Yes | null | Cluster 30: Non-specific - DNA binding | Cluster 13: Oligodendrocytes - Mixed function | Cluster 38: Non-specific - Transcription | Cluster 22: Non-specific - Basic cellular functions | Cluster 80: Thymus - Adaptive immune response | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | 3,876 | 3 |
ENSG00000111644 | ACRBP | Acrosin binding protein | [
"Q8NEB7"
] | 12 | 6638075-6647433 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA039081",
"HPA039082"
] | [
"CT23",
"OY-TES-1",
"SP32"
] | [
"Predicted secreted proteins"
] | [] | [] | [] | [
"Nucleoplasm",
"Vesicles"
] | [
"Cytosol"
] | [
"Secreted in male reproductive system"
] | [
"No annotated function"
] | Approved | Enhanced | null | 5 | null | null | Cluster 40: Monocytes - Innate immune response | Cluster 6: Non-specific - Immune response | Cluster 14: Myeloid leukemia - Innate immune response | Cluster 47: Platelets - Hemostasis | Cluster 57: Testis - Spermatogenesis | Tissue enriched | Detected in many | 20 | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Group enriched | Detected in many | 9 | Group enriched | Detected in many | 4 | 0 | 0 | 0 | [] | [] | [] | 3,877 | 7 |
ENSG00000111647 | BLTP3B | Bridge-like lipid transfer protein family member 3B | [
"A0JNW5"
] | 12 | 100028455-100142874 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA039671",
"HPA075150"
] | [
"KIAA0701",
"SHIP164",
"UHRF1BP1L"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nucleoplasm"
] | [
"Vesicles",
"Cytosol"
] | [] | [] | Uncertain | Uncertain | null | 32 | null | null | Cluster 41: Basophils - Unknown function | Cluster 31: Non-specific - Transcription | Cluster 38: Non-specific - Transcription | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma"
] | 3,878 | 2 |
ENSG00000111652 | COPS7A | COP9 signalosome subunit 7A | [
"Q9UBW8"
] | 12 | 6724014-6731875 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA026915"
] | [
"CSN7A"
] | [
"Predicted intracellular proteins"
] | [
"Host-virus interaction"
] | [] | [] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Supported | Supported | null | 70 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 38: Non-specific - Transcription | Cluster 97: Non-specific - Cellular respiration | Cluster 25: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Colon Adenocarcinoma"
] | [
"Colon Adenocarcinoma"
] | 3,879 | 6 |
ENSG00000111653 | ING4 | Inhibitor of growth family member 4 | [
"Q9UNL4"
] | 12 | 6650301-6663142 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA031817",
"HPA057338"
] | [
"my036",
"p29ING4"
] | [
"Predicted intracellular proteins"
] | [
"Apoptosis",
"Cell cycle"
] | [
"Chromatin regulator"
] | [
"Tumor suppressor"
] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Approved | null | 36 | Yes | No | Cluster 42: Non-specific - Vesicular transport | Cluster 28: Oligodendrocytes - Mixed function | Cluster 38: Non-specific - Transcription | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Papillary Cell Carcinoma"
] | [] | [
"Kidney Renal Papillary Cell Carcinoma"
] | 3,880 | 9 |
ENSG00000111665 | CDCA3 | Cell division cycle associated 3 | [
"Q99618"
] | 12 | 6844793-6851292 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA026587"
] | [
"GRCC8",
"TOME-1"
] | [
"Predicted intracellular proteins"
] | [
"Cell cycle",
"Cell division",
"Mitosis",
"Ubl conjugation pathway"
] | [] | [] | [
"Cytosol"
] | [] | [] | [] | Approved | null | null | 29 | null | Yes | Cluster 14: Non-specific - Unknown function | Cluster 37: Neurons - Mixed function | Cluster 38: Non-specific - Transcription | Cluster 27: Non-specific - Cell proliferation | Cluster 32: Retina & Lymphoid tissues - Signaling | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in some | null | 6 | 6 | 3 | [] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 3,882 | 5 |
ENSG00000111666 | CHPT1 | Choline phosphotransferase 1 | [
"Q8WUD6"
] | 12 | 101696947-101744140 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA067643"
] | [
"CPT1"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted membrane proteins"
] | [
"Lipid biosynthesis",
"Lipid metabolism",
"Phospholipid biosynthesis",
"Phospholipid metabolism"
] | [
"Transferase"
] | [] | [
"Vesicles"
] | [] | [] | [] | Supported | Approved | null | 6 | null | null | Cluster 22: Eosinophils - Transcription | Cluster 39: Astrocytes - Mixed function | Cluster 60: Prostate cancer - Unknown function | Cluster 87: B-cells - Adaptive immunity: Humoral response | Cluster 76: Non-specific - Metabolism | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Group enriched | Detected in many | 6 | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Glioblastoma Multiforme"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | 3,883 | 6 |
ENSG00000111667 | USP5 | Ubiquitin specific peptidase 5 | [
"P45974"
] | 12 | 6852148-6866632 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA006756"
] | [
"IsoT"
] | [
"Enzymes",
"Essential proteins",
"Metabolic proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Ubl conjugation pathway"
] | [
"Hydrolase",
"Protease",
"Thiol protease"
] | [] | [
"Nucleoplasm",
"Cytosol"
] | [] | [] | [] | Approved | Uncertain | null | 38 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 1: Neurons - Mixed function | Cluster 38: Non-specific - Transcription | Cluster 97: Non-specific - Cellular respiration | Cluster 25: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 3,884 | 8 |
ENSG00000111669 | TPI1 | Triosephosphate isomerase 1 | [
"P60174"
] | 12 | 6867119-6870948 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA050924",
"HPA053568"
] | [] | [
"Cancer-related genes",
"Disease related genes",
"Enzymes",
"Essential proteins",
"Human disease related genes",
"Metabolic proteins",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Gluconeogenesis",
"Glycolysis"
] | [
"Isomerase",
"Lyase"
] | [
"Cancer-related genes",
"Disease variant",
"Hereditary hemolytic anemia"
] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Uncertain | null | 32 | null | null | Cluster 29: Non-specific - Unknown function | Cluster 14: Neurons - Synaptic function | Cluster 38: Non-specific - Transcription | Cluster 85: Squamous epithelial cells - Keratinization | Cluster 52: Non-specific - Cellular respiration | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [] | [
"Bladder Urothelial Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Bladder Urothelial Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 3,885 | 4 |
ENSG00000111670 | GNPTAB | N-acetylglucosamine-1-phosphate transferase subunits alpha and beta | [
"Q3T906"
] | 12 | 101745499-101830959 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA014558",
"HPA042343"
] | [
"GNPTA",
"KIAA1208",
"MGC4170"
] | [
"Cancer-related genes",
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [
"Transferase"
] | [
"Cancer-related genes",
"Disease variant",
"Mucolipidosis"
] | [
"Golgi apparatus"
] | [] | [] | [] | Supported | Approved | null | 7 | null | null | Cluster 3: Non-specific - Nuclear processes | Cluster 51: Neurons - Mixed function | Cluster 9: Skin cancer - Melanin biosynthesis | Cluster 60: Cardiomyocytes - Cardiac muscle contraction & structure | Cluster 29: Lymphoid tissue & Bone marrow - Innate immune response | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 3,886 | 3 |
ENSG00000111671 | SPSB2 | SplA/ryanodine receptor domain and SOCS box containing 2 | [
"Q99619"
] | 12 | 6870935-6889358 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA055225"
] | [
"GRCC9",
"SSB-2"
] | [
"Predicted intracellular proteins"
] | [
"Host-virus interaction",
"Ubl conjugation pathway"
] | [] | [] | [] | [] | [] | [] | null | Approved | null | 51 | null | null | Cluster 29: Non-specific - Unknown function | Cluster 25: Non-specific - Transcription | Cluster 15: Kidney cancer - Membrane components | Cluster 65: Non-specific - Cell growth & division | Cluster 72: Kidney - Transmembrane transport | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 2 | 0 | 2 | [] | [
"Bladder Urothelial Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Bladder Urothelial Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 3,887 | 2 |
ENSG00000111674 | ENO2 | Enolase 2 | [
"P09104"
] | 12 | 6913745-6923698 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB000063",
"HPA068284",
"HPA068721",
"CAB073539",
"CAB079023"
] | [
"NSE"
] | [
"Cancer-related genes",
"Candidate cardiovascular disease genes",
"Enzymes",
"Metabolic proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Glycolysis"
] | [
"Lyase"
] | [
"Cancer-related genes"
] | [
"Plasma membrane",
"Cytosol"
] | [] | [] | [] | Enhanced | Enhanced | Supported | 12 | null | null | Cluster 43: Non-specific - Transcription & Translation | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 15: Kidney cancer - Membrane components | Cluster 79: Photoreceptor cells - Phototransduction | Cluster 46: Brain & retina - Neuronal signaling | Group enriched | Detected in all | 7 | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in many | 4 | 4 | 0 | 4 | [
"Bladder Urothelial Carcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Bladder Urothelial Carcinoma",
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 3,888 | 1 |
ENSG00000111676 | ATN1 | Atrophin 1 | [
"P54259"
] | 12 | 6924463-6942321 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA023990",
"HPA031619"
] | [
"B37",
"D12S755E",
"DRPLA"
] | [
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Transcription",
"Transcription regulation"
] | [] | [
"Disease variant",
"Epilepsy",
"Intellectual disability",
"Neurodegeneration"
] | [
"Nucleoplasm"
] | [] | [] | [] | Enhanced | Enhanced | null | 33 | null | null | Cluster 22: Eosinophils - Transcription | Cluster 4: Non-specific - mRNA splicing & Cell cycle | Cluster 38: Non-specific - Transcription | Cluster 17: Non-specific - RNA processing | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 3,889 | 5 |
ENSG00000111679 | PTPN6 | Protein tyrosine phosphatase non-receptor type 6 | [
"P29350"
] | 12 | 6946468-6961316 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA001466",
"CAB004572",
"CAB072845"
] | [
"HCP",
"HCPH",
"PTP-1C",
"SHP-1",
"SHP1"
] | [
"Enzymes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [
"Hydrolase",
"Protein phosphatase"
] | [] | [
"Nucleoplasm"
] | [
"Nucleoli"
] | [] | [] | Supported | Enhanced | null | 96 | null | null | Cluster 29: Non-specific - Unknown function | Cluster 20: Macrophages & Microglia - Immune response | Cluster 46: Lymphoma - Humoral immune response | Cluster 40: Monocytes & Neutrophils - Inflammatory signaling | Cluster 66: Lymphoid tissue - Immune response | Tissue enhanced | Detected in many | null | Group enriched | Detected in many | 5 | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 3,891 | 9 |
ENSG00000111684 | LPCAT3 | Lysophosphatidylcholine acyltransferase 3 | [
"Q6P1A2"
] | 12 | 6976185-7018477 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"C3F",
"LPLAT12",
"MBOAT5",
"nessy",
"OACT5"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted membrane proteins"
] | [
"Lipid biosynthesis",
"Lipid metabolism",
"Phospholipid biosynthesis",
"Phospholipid metabolism"
] | [
"Acyltransferase",
"Transferase"
] | [] | [] | [] | [] | [] | null | null | null | 8 | null | null | Cluster 25: Non-specific - Unknown function | Cluster 25: Non-specific - Transcription | Cluster 18: Liver cancer - Metabolism | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 77: Intestine - Digestion | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 3,892 | 5 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.